US2745785A
(en)
|
1952-10-29 |
1956-05-15 |
American Home Prod |
Therapeutic composition comprising tabular nu, nu'-dibenzylethylenediamine di-penicillin, and process for preparing same
|
US4798846A
(en)
|
1974-03-28 |
1989-01-17 |
Imperial Chemical Industries Plc |
Pharmaceutical compositions
|
GB1472793A
(en)
|
1974-03-28 |
1977-05-04 |
Ici Ltd |
Pharmaceutical compositions
|
US4073943A
(en)
|
1974-09-11 |
1978-02-14 |
Apoteksvarucentralen Vitrum Ab |
Method of enhancing the administration of pharmalogically active agents
|
DE3013839A1
(de)
|
1979-04-13 |
1980-10-30 |
Freunt Ind Co Ltd |
Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
|
US4622219A
(en)
|
1983-06-17 |
1986-11-11 |
Haynes Duncan H |
Method of inducing local anesthesia using microdroplets of a general anesthetic
|
US4725442A
(en)
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
US4608278A
(en)
|
1983-06-22 |
1986-08-26 |
The Ohio State University Research Foundation |
Small particule formation and encapsulation
|
CA1282405C
(en)
|
1984-05-21 |
1991-04-02 |
Michael R. Violante |
Method for making uniformly sized particles from water-insoluble organic compounds
|
US4826689A
(en)
*
|
1984-05-21 |
1989-05-02 |
University Of Rochester |
Method for making uniformly sized particles from water-insoluble organic compounds
|
US4606940A
(en)
|
1984-12-21 |
1986-08-19 |
The Ohio State University Research Foundation |
Small particle formation and encapsulation
|
US5354563A
(en)
|
1985-07-15 |
1994-10-11 |
Research Development Corp. Of Japan |
Water dispersion containing ultrafine particles of organic compounds
|
US5023271A
(en)
|
1985-08-13 |
1991-06-11 |
California Biotechnology Inc. |
Pharmaceutical microemulsions
|
CA1338736C
(fr)
|
1986-12-05 |
1996-11-26 |
Roger Baurain |
Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
|
US5174930A
(en)
|
1986-12-31 |
1992-12-29 |
Centre National De La Recherche Scientifique (Cnrs) |
Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions
|
FR2608988B1
(fr)
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
|
FR2608942B1
(fr)
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
|
FR2634397B2
(fr)
|
1986-12-31 |
1991-04-19 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une proteine sous forme de nanoparticules
|
IL86211A
(en)
|
1987-05-04 |
1992-03-29 |
Ciba Geigy Ag |
Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
|
GB8901254D0
(en)
|
1989-01-20 |
1989-03-15 |
Allied Colloids Ltd |
Particulate materials and their production
|
FR2631826B1
(fr)
|
1988-05-27 |
1992-06-19 |
Centre Nat Rech Scient |
Vecteur particulaire utile notamment pour le transport de molecules a activite biologique et procede pour sa preparation
|
US5269979A
(en)
|
1988-06-08 |
1993-12-14 |
Fountain Pharmaceuticals, Inc. |
Method for making solvent dilution microcarriers
|
IL90561A
(en)
|
1988-06-08 |
1993-08-18 |
Fountain Pharm Inc |
Method for making solvent dilution microcarriers
|
EP0349428B1
(fr)
|
1988-06-30 |
1993-01-20 |
Centre National De La Recherche Scientifique (Cnrs) |
Procédé de préparation de systèmes colloidaux dispersibles d'une protéine, sous forme de nanoparticules
|
US5707634A
(en)
|
1988-10-05 |
1998-01-13 |
Pharmacia & Upjohn Company |
Finely divided solid crystalline powders via precipitation into an anti-solvent
|
JP2843857B2
(ja)
|
1988-10-05 |
1999-01-06 |
ファルマシア・アンド・アップジョン・カンパニー |
反溶剤への沈澱を介する微細分化固体結晶性粉末
|
US5474989A
(en)
|
1988-11-11 |
1995-12-12 |
Kurita Water Industries, Ltd. |
Drug composition
|
IL92344A0
(en)
|
1989-01-04 |
1990-07-26 |
Gist Brocades Nv |
Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
|
SE464743B
(sv)
|
1989-06-21 |
1991-06-10 |
Ytkemiska Inst |
Foerfarande foer framstaellning av laekemedelspartiklar
|
CH677886A5
(no)
|
1989-06-26 |
1991-07-15 |
Hans Georg Prof Dr Weder |
|
FR2651680B1
(fr)
|
1989-09-14 |
1991-12-27 |
Medgenix Group Sa |
Nouveau procede de preparation de microparticules lipidiques.
|
DK546289D0
(da)
|
1989-11-02 |
1989-11-02 |
Danochemo As |
Carotenoidpulvere
|
US5188837A
(en)
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
DE4005711C1
(no)
|
1990-02-23 |
1991-06-13 |
A. Nattermann & Cie Gmbh, 5000 Koeln, De |
|
US5078994A
(en)
|
1990-04-12 |
1992-01-07 |
Eastman Kodak Company |
Microgel drug delivery system
|
US5091187A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
US5246707A
(en)
|
1990-04-26 |
1993-09-21 |
Haynes Duncan H |
Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
US5407683A
(en)
*
|
1990-06-01 |
1995-04-18 |
Research Corporation Technologies, Inc. |
Pharmaceutical solutions and emulsions containing taxol
|
DE69112917T2
(de)
|
1990-06-15 |
1996-05-15 |
Merck & Co Inc |
Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
|
IT1246350B
(it)
|
1990-07-11 |
1994-11-17 |
Eurand Int |
Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
|
CA2046830C
(en)
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
US5552160A
(en)
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
AU642066B2
(en)
|
1991-01-25 |
1993-10-07 |
Nanosystems L.L.C. |
X-ray contrast compositions useful in medical imaging
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
IT1247472B
(it)
|
1991-05-31 |
1994-12-17 |
Fidia Spa |
Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
|
US5766635A
(en)
|
1991-06-28 |
1998-06-16 |
Rhone-Poulenc Rorer S.A. |
Process for preparing nanoparticles
|
US5250236A
(en)
|
1991-08-05 |
1993-10-05 |
Gasco Maria R |
Method for producing solid lipid microspheres having a narrow size distribution
|
CA2078388A1
(en)
|
1991-10-02 |
1993-04-03 |
Mridula Nair |
Biocompatible emulsion particles
|
US6063910A
(en)
|
1991-11-14 |
2000-05-16 |
The Trustees Of Princeton University |
Preparation of protein microparticles by supercritical fluid precipitation
|
IL101007A
(en)
*
|
1992-02-18 |
1997-08-14 |
Pharmos Ltd |
Dry stable compositions prepared by lyophilization
|
US5298483A
(en)
|
1992-03-30 |
1994-03-29 |
Tropicana Products, Inc. |
New matter of composition and method for using the same as plant bioregulators
|
US5389263A
(en)
|
1992-05-20 |
1995-02-14 |
Phasex Corporation |
Gas anti-solvent recrystallization and application for the separation and subsequent processing of RDX and HMX
|
DE69309056T2
(de)
|
1992-06-10 |
1997-09-18 |
Nanosystems Llc |
Oberflaechenmodifizierte nsaid nanopartikeln
|
SE9202128D0
(sv)
|
1992-07-09 |
1992-07-09 |
Astra Ab |
Precipitation of one or more active compounds in situ
|
US5466646A
(en)
|
1992-08-18 |
1995-11-14 |
Worcester Polytechnic Institute |
Process for the preparation of solid state materials and said materials
|
US5417956A
(en)
|
1992-08-18 |
1995-05-23 |
Worcester Polytechnic Institute |
Preparation of nanophase solid state materials
|
AU660852B2
(en)
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
US5346702A
(en)
|
1992-12-04 |
1994-09-13 |
Sterling Winthrop Inc. |
Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
|
US5298262A
(en)
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
US5302401A
(en)
|
1992-12-09 |
1994-04-12 |
Sterling Winthrop Inc. |
Method to reduce particle size growth during lyophilization
|
US5340564A
(en)
|
1992-12-10 |
1994-08-23 |
Sterling Winthrop Inc. |
Formulations comprising olin 10-G to prevent particle aggregation and increase stability
|
US5336507A
(en)
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
US5429824A
(en)
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
US5352459A
(en)
|
1992-12-16 |
1994-10-04 |
Sterling Winthrop Inc. |
Use of purified surface modifiers to prevent particle aggregation during sterilization
|
US5326552A
(en)
|
1992-12-17 |
1994-07-05 |
Sterling Winthrop Inc. |
Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
|
DE4305003A1
(de)
|
1993-02-18 |
1994-08-25 |
Knoll Ag |
Verfahren zur Herstellung kolloidaler wäßriger Lösungen schwer löslicher Wirkstoffe
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US5665383A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US5885486A
(en)
|
1993-03-05 |
1999-03-23 |
Pharmaciaand Upjohn Ab |
Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
FR2703927B1
(fr)
|
1993-04-13 |
1995-07-13 |
Coletica |
Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une polyamine pour former en milieu aqueux une membrane au moins en surface de particules gélifiées.
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
DE4327063A1
(de)
|
1993-08-12 |
1995-02-16 |
Kirsten Dr Westesen |
Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
|
US5500161A
(en)
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
SE9303574D0
(sv)
|
1993-11-01 |
1993-11-01 |
Kabi Pharmacia Ab |
Composition for drug delivery and method the manufacturing thereof
|
US5415869A
(en)
*
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
UA40634C2
(uk)
|
1993-11-15 |
2001-08-15 |
Зенека Лімітед |
Мікрокапсула, яка містить суспензію твердої біологічно активної сполуки, і спосіб її одержання
|
JP2699839B2
(ja)
|
1993-12-03 |
1998-01-19 |
日本電気株式会社 |
半導体装置の製造方法
|
IE940292A1
(en)
|
1994-04-06 |
1995-10-18 |
Elan Corp Plc |
Biodegradable microcapsules and method for their manufacture
|
TW384224B
(en)
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
FR2721510B1
(fr)
|
1994-06-22 |
1996-07-26 |
Rhone Poulenc Rorer Sa |
Nanoparticules filtrables dans des conditions stériles.
|
US5587143A
(en)
|
1994-06-28 |
1996-12-24 |
Nanosystems L.L.C. |
Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
GB9413202D0
(en)
|
1994-06-30 |
1994-08-24 |
Univ Bradford |
Method and apparatus for the formation of particles
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
RU2147243C1
(ru)
|
1994-09-27 |
2000-04-10 |
Нюкомед Имагинг А/С |
Контрастное средство
|
US5720551A
(en)
|
1994-10-28 |
1998-02-24 |
Shechter; Tal |
Forming emulsions
|
SE9403846D0
(sv)
|
1994-11-09 |
1994-11-09 |
Univ Ohio State Res Found |
Small particle formation
|
DE4440337A1
(de)
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
ATE252894T1
(de)
|
1995-01-05 |
2003-11-15 |
Univ Michigan |
Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
|
US5662883A
(en)
|
1995-01-10 |
1997-09-02 |
Nanosystems L.L.C. |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
|
US5716642A
(en)
|
1995-01-10 |
1998-02-10 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
|
US5665331A
(en)
|
1995-01-10 |
1997-09-09 |
Nanosystems L.L.C. |
Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
|
US5560932A
(en)
|
1995-01-10 |
1996-10-01 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents
|
US5569448A
(en)
|
1995-01-24 |
1996-10-29 |
Nano Systems L.L.C. |
Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
ES2154806T3
(es)
|
1995-02-06 |
2001-04-16 |
Elan Pharma Int Ltd |
Formulaciones de compuestos como dispersiones de nanoparticulas en aceites o acidos grasos digeribles.
|
US5518738A
(en)
|
1995-02-09 |
1996-05-21 |
Nanosystem L.L.C. |
Nanoparticulate nsaid compositions
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
US5591456A
(en)
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
US5573783A
(en)
|
1995-02-13 |
1996-11-12 |
Nano Systems L.L.C. |
Redispersible nanoparticulate film matrices with protective overcoats
|
US5543133A
(en)
|
1995-02-14 |
1996-08-06 |
Nanosystems L.L.C. |
Process of preparing x-ray contrast compositions containing nanoparticles
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
US5580579A
(en)
|
1995-02-15 |
1996-12-03 |
Nano Systems L.L.C. |
Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
|
WO1996025918A1
(en)
|
1995-02-24 |
1996-08-29 |
Nanosystems L.L.C. |
Aerosols containing nanoparticle dispersions
|
US5605785A
(en)
|
1995-03-28 |
1997-02-25 |
Eastman Kodak Company |
Annealing processes for nanocrystallization of amorphous dispersions
|
DE69618938T2
(de)
|
1995-03-28 |
2002-10-31 |
Fidia Advanced Biopolymers Srl |
Nanosphären mit einem biokompatiblen polysaccharid
|
IE75744B1
(en)
|
1995-04-03 |
1997-09-24 |
Elan Corp Plc |
Controlled release biodegradable micro- and nanospheres containing cyclosporin
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
SE9501384D0
(sv)
|
1995-04-13 |
1995-04-13 |
Astra Ab |
Process for the preparation of respirable particles
|
GB9511220D0
(en)
|
1995-06-02 |
1995-07-26 |
Glaxo Group Ltd |
Solid dispersions
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
ES2177592T3
(es)
|
1995-07-05 |
2002-12-16 |
Europ Economic Community |
Nanoparticulas biocompatibles y biodegradables para la absorcion y administracion de medicamentos proteinicos.
|
GB9514878D0
(en)
*
|
1995-07-20 |
1995-09-20 |
Danbiosyst Uk |
Vitamin E as a solubilizer for drugs contained in lipid vehicles
|
US6143211A
(en)
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
TW487582B
(en)
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
DE69637441T2
(de)
|
1995-10-17 |
2009-03-05 |
Jagotec Ag |
Verabreichung unlöslicher arzneistoffe
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
US6245349B1
(en)
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
IL117773A
(en)
|
1996-04-02 |
2000-10-31 |
Pharmos Ltd |
Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
|
US5660858A
(en)
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
US6231890B1
(en)
|
1996-05-02 |
2001-05-15 |
Taisho Pharmaceutical Co., Ltd. |
Suspension of sparingly water-soluble acidic drug
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
ATE223206T1
(de)
|
1996-05-07 |
2002-09-15 |
Alkermes Inc |
Verfahren zur herstellung von mikropartikeln
|
CA2240161C
(en)
|
1996-05-20 |
2005-05-24 |
Janssen Pharmaceutica N.V. |
Antifungal compositions with improved bioavailability
|
CA2263765C
(en)
|
1996-08-19 |
2010-03-30 |
Vivorx Pharmaceuticals, Inc. |
Methods for the production of protein particles useful for delivery of pharmacological agents
|
DE69734988T2
(de)
|
1996-08-22 |
2006-09-21 |
Jagotec Ag |
Zubereitungen enthaltend mikropartikel von wasserunlöslichen stoffen und verfahren zu deren herstellung
|
US6344271B1
(en)
|
1998-11-06 |
2002-02-05 |
Nanoenergy Corporation |
Materials and products using nanostructured non-stoichiometric substances
|
DE19637517A1
(de)
|
1996-09-13 |
1998-03-19 |
Basf Ag |
Herstellung von pulverförmigen, kaltwasserdispergierbaren Carotinoid-Zubereitungen und die Verwendung der neuen Carotinoid-Zubereitungen
|
US6048550A
(en)
|
1996-10-03 |
2000-04-11 |
Chan; Daniel C. F. |
Hydrophilic microparticles and methods to prepare same
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US5874111A
(en)
|
1997-01-07 |
1999-02-23 |
Maitra; Amarnath |
Process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles
|
WO1998035666A1
(en)
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
US6045829A
(en)
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
IT1292142B1
(it)
|
1997-06-12 |
1999-01-25 |
Maria Rosa Gasco |
Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
|
KR19990001564A
(ko)
|
1997-06-16 |
1999-01-15 |
유충식 |
용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
|
BRPI9810945B8
(pt)
|
1997-06-27 |
2021-05-25 |
Abraxis Bioscience Inc |
formulações de agentes farmacológicos, métodos para sua preparação e métodos para uso das mesmas
|
US6217886B1
(en)
|
1997-07-14 |
2001-04-17 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved micelle compositions
|
US20020115609A1
(en)
|
1997-07-14 |
2002-08-22 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
WO1999003450A1
(fr)
|
1997-07-15 |
1999-01-28 |
Coletica |
Particules, en particulier micro- ou nanoparticules de proteines vegetales reticulees, leur procede de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
|
DE19737481A1
(de)
|
1997-08-28 |
1999-03-04 |
Hoechst Ag |
Sphärische lineare Polysaccharide enthaltende Mikropartikel
|
FI973804A
(fi)
|
1997-09-26 |
1999-03-27 |
Orion Yhtymae Oy |
Levosimendaanin oraalisia koostumuksia
|
US6221322B1
(en)
|
1997-11-27 |
2001-04-24 |
Dowa Mining Co., Ltd |
Strontium nitrate and method for manufacturing same
|
EP1039893B1
(en)
|
1997-12-10 |
2011-02-02 |
Cyclosporine Therapeutics Limited |
Pharmaceutical compositions containing an omega-3 fatty acid oil
|
DE69814918T2
(de)
|
1997-12-17 |
2004-03-11 |
Universidad De Sevilla |
Vorrichtung und verfahren zur erzeugung von aerosolen für arzneimittelverabreichung
|
US6066292A
(en)
|
1997-12-19 |
2000-05-23 |
Bayer Corporation |
Sterilization process for pharmaceutical suspensions
|
JP3696087B2
(ja)
|
1997-12-31 |
2005-09-14 |
チョンワエ ファーマ コーポレーション |
イトラコナゾール(itraconazole)経口用製剤及びその製造方法
|
US6086376A
(en)
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
US6337092B1
(en)
|
1998-03-30 |
2002-01-08 |
Rtp Pharma Inc. |
Composition and method of preparing microparticles of water-insoluble substances
|
WO1999049846A2
(en)
|
1998-03-30 |
1999-10-07 |
Rtp Pharma Inc. |
Compositions containing microparticles of water-insoluble substances and method for their preparation
|
CA2326485C
(en)
|
1998-04-01 |
2008-12-09 |
Rtp Pharma Inc. |
Anticancer compositions
|
US6979456B1
(en)
*
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
DK1071402T3
(da)
|
1998-04-09 |
2007-02-19 |
Hoffmann La Roche |
Fremgangsmåde til af partikler med (sub)mikronstörrelse ved oplösning i komprimeret gas og overfladeaktive stoffer
|
FR2777193B1
(fr)
|
1998-04-14 |
2001-06-08 |
Coletica |
Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
|
IL139541A0
(en)
|
1998-05-20 |
2004-02-08 |
Liposome Co Inc |
Novel particulate formulations
|
ATE259220T1
(de)
|
1998-05-29 |
2004-02-15 |
Skyepharma Canada Inc |
Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
|
JP4693238B2
(ja)
|
1998-06-19 |
2011-06-01 |
オバン・エナジー・リミテッド |
水に溶けない化合物のサブミクロン粒子を生成させる方法
|
FR2780901B1
(fr)
|
1998-07-09 |
2000-09-29 |
Coletica |
Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
|
US6153225A
(en)
|
1998-08-13 |
2000-11-28 |
Elan Pharma International Limited |
Injectable formulations of nanoparticulate naproxen
|
US6238677B1
(en)
|
1998-08-18 |
2001-05-29 |
The United States Of America As Represented By The Secretary Of Agriculture |
Starch microcapsules for delivery of active agents
|
ATE452651T1
(de)
|
1998-09-01 |
2010-01-15 |
Merrion Res Iii Ltd |
Orale impfstoff-zusammensetzung
|
ATE322285T1
(de)
|
1998-09-01 |
2006-04-15 |
Elan Corp Plc |
Verfahren zur induktion der zellulären immunantwort und parenterale impfstoff- zusammensetzungen dazu
|
US6165506A
(en)
|
1998-09-04 |
2000-12-26 |
Elan Pharma International Ltd. |
Solid dose form of nanoparticulate naproxen
|
US6350786B1
(en)
|
1998-09-22 |
2002-02-26 |
Hoffmann-La Roche Inc. |
Stable complexes of poorly soluble compounds in ionic polymers
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
EP2266542A3
(en)
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
SK288117B6
(sk)
|
1998-11-20 |
2013-09-03 |
Skyepharma Canada Inc. |
Rapidly dispersing solid dry therapeutic dosage form
|
AU767737B2
(en)
|
1998-11-20 |
2003-11-20 |
Skyepharma Canada Inc. |
Method of preparing stable suspensions of insoluble microparticles
|
JP2002532535A
(ja)
|
1998-12-22 |
2002-10-02 |
アメリカ合衆国 |
水不溶性薬剤送達システム
|
JP2002534371A
(ja)
|
1999-01-06 |
2002-10-15 |
コリア リサーチ インスティテュート オブ ケミカル テクノロジー |
水不溶性薬物を含む医薬的活性成分の製造方法及びそれを含む経口投与用医薬組成物
|
US6365191B1
(en)
|
1999-02-17 |
2002-04-02 |
Dabur Research Foundation |
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6294192B1
(en)
*
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6270806B1
(en)
|
1999-03-03 |
2001-08-07 |
Elan Pharma International Limited |
Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
|
US6267989B1
(en)
|
1999-03-08 |
2001-07-31 |
Klan Pharma International Ltd. |
Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
|
US6045826A
(en)
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
US6632443B2
(en)
|
2000-02-23 |
2003-10-14 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
CA2371912C
(en)
|
1999-05-21 |
2010-02-16 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
KR100331529B1
(ko)
|
1999-06-16 |
2002-04-06 |
민경윤 |
난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
SE0100823D0
(sv)
|
2001-03-09 |
2001-03-09 |
Astrazeneca Ab |
Method I to obtain microparticles
|
WO2001021154A2
(en)
|
1999-09-21 |
2001-03-29 |
Rtp Pharma Inc. |
Surface modified particulate compositions of biologically active substances
|
CZ20022332A3
(cs)
|
2000-01-07 |
2003-01-15 |
Transform Pharmaceuticals, Inc. |
Sestava vzorků
|
DE10007816A1
(de)
|
2000-02-21 |
2001-09-06 |
Bayer Ag |
Verfahren zur Herstellung von Nanosuspensionen
|
AU4724401A
(en)
|
2000-02-28 |
2001-09-12 |
Genesegues Inc |
Nanocapsule encapsulation system and method
|
JP5102423B2
(ja)
|
2000-04-20 |
2012-12-19 |
オバン・エナジー・リミテッド |
改善された水不溶性薬剤粒子の処理
|
JP4763957B2
(ja)
|
2000-05-10 |
2011-08-31 |
オバン・エナジー・リミテッド |
メディアミリング
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
CA2419115C
(en)
|
2000-08-15 |
2011-03-08 |
Board Of Trustees Of The University Of Illinois |
Microparticles, and method and apparatus for forming same
|
ATE424811T1
(de)
|
2000-08-31 |
2009-03-15 |
Jagotec Ag |
Gemahlene partikel
|
AU6294501A
(en)
|
2000-09-20 |
2002-04-02 |
Rtp Pharma Inc |
Spray drying process and compositions of fenofibrate
|
KR100822684B1
(ko)
*
|
2000-10-04 |
2008-04-17 |
교와 핫꼬 고교 가부시끼가이샤 |
지질막에 의한 미립자의 피복방법
|
US7105176B2
(en)
|
2000-11-29 |
2006-09-12 |
Basf Aktiengesellschaft |
Production of solid preparations of water-soluble, sparingly water-soluble or water-insoluble active compounds
|
AU2002222115B2
(en)
|
2000-11-30 |
2006-09-28 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20040022862A1
(en)
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US20040256749A1
(en)
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
JP4376518B2
(ja)
|
2000-12-22 |
2009-12-02 |
バクスター・インターナショナル・インコーポレイテッド |
サブミクロン粒子の懸濁物を調製する方法
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US6607784B2
(en)
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20030072807A1
(en)
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
DE60130580T2
(de)
|
2000-12-27 |
2008-06-12 |
Ares Trading S.A. |
Lipidmikropartikel mittels kryogenischer mikronisierung
|
JP2004517699A
(ja)
|
2001-01-30 |
2004-06-17 |
ボード オブ リージェンツ ユニバーシティ オブ テキサス システム |
液体中への噴霧凍結によるナノ粒子およびミクロ粒子の製造方法
|
SE0100822D0
(sv)
|
2001-03-09 |
2001-03-09 |
Astrazeneca Ab |
Method II to obtain microparticles
|
SE0100901D0
(sv)
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
New composition
|
AU2002312777B2
(en)
|
2001-03-27 |
2007-07-05 |
Phares Pharmaceutical Research N.V. |
Method and composition for solubilising a biologically active compound with low water solubility
|
KR100607742B1
(ko)
|
2001-04-03 |
2006-08-01 |
쉐링 코포레이션 |
안정한 액상 현탁제, 및 이를 함유하는, 생체 이용율이 증진된 항진균성 조성물
|
AR033711A1
(es)
|
2001-05-09 |
2004-01-07 |
Novartis Ag |
Composiciones farmaceuticas
|
AU2002337692B2
(en)
|
2001-09-26 |
2007-09-13 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
EP1628641A2
(en)
|
2003-05-19 |
2006-03-01 |
Baxter International Inc. |
Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers
|